Pages that link to "Q41721011"
Jump to navigation
Jump to search
The following pages link to Polyethylene glycol modification of the monoclonal antibody A7 enhances its tumor localization (Q41721011):
Displaying 12 items.
- A Better Anti-Diabetic Recombinant Human Fibroblast Growth Factor 21 (rhFGF21) Modified with Polyethylene Glycol (Q28478454) (← links)
- Extravasation of macromolecules (Q33933325) (← links)
- Acceleration of diabetic-wound healing with PEGylated rhaFGF in healing-impaired streptozocin diabetic rats (Q34076711) (← links)
- Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region (Q34194728) (← links)
- Site specific discrete PEGylation of (124)I-labeled mCC49 Fab' fragments improves tumor MicroPET/CT imaging in mice (Q34555580) (← links)
- PEGylated antibodies and antibody fragments for improved therapy: a review (Q34674773) (← links)
- Enhanced tumour specificity of an anti-carcinoembrionic antigen Fab' fragment by poly(ethylene glycol) (PEG) modification (Q36134492) (← links)
- Site-specific chemical modification with polyethylene glycol of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) improves antitumor activity and reduces animal toxicity and immunogenicity (Q37232738) (← links)
- Modulating antibody pharmacokinetics using hydrophilic polymers (Q37919888) (← links)
- Antibody-targeted drugs for the therapy of cancer (Q40563987) (← links)
- Polyethylene glycol modification: relevance of improved methodology to tumour targeting (Q41160079) (← links)
- Comparative pharmacokinetic properties of murine monoclonal antibody A7 modified with neocarzinostatin, dextran and polyethylene glycol. (Q55266469) (← links)